<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
	<id>https://www.na-mic.org/w/index.php?action=history&amp;feed=atom&amp;title=Projects%3ALiverFibrosisStaging</id>
	<title>Projects:LiverFibrosisStaging - Revision history</title>
	<link rel="self" type="application/atom+xml" href="https://www.na-mic.org/w/index.php?action=history&amp;feed=atom&amp;title=Projects%3ALiverFibrosisStaging"/>
	<link rel="alternate" type="text/html" href="https://www.na-mic.org/w/index.php?title=Projects:LiverFibrosisStaging&amp;action=history"/>
	<updated>2026-04-10T15:48:26Z</updated>
	<subtitle>Revision history for this page on the wiki</subtitle>
	<generator>MediaWiki 1.33.0</generator>
	<entry>
		<id>https://www.na-mic.org/w/index.php?title=Projects:LiverFibrosisStaging&amp;diff=78298&amp;oldid=prev</id>
		<title>Anry: /* Segmentation */</title>
		<link rel="alternate" type="text/html" href="https://www.na-mic.org/w/index.php?title=Projects:LiverFibrosisStaging&amp;diff=78298&amp;oldid=prev"/>
		<updated>2012-11-21T18:38:51Z</updated>

		<summary type="html">&lt;p&gt;&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;Segmentation&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;en&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;← Older revision&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #222; text-align: center;&quot;&gt;Revision as of 18:38, 21 November 2012&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Line 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Line 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;= &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;Segmentation &lt;/del&gt;=&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;= &lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Liver Fibrosis Staging &lt;/ins&gt;=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;This project is conducted in collaboration with the Boston Medical Center. We are trying to provide tools for robust liver ﬁbrosis staging, based on MRI image analysis. The current practice of ﬁbrosis assessment, which is based on painful liver biopsy, might be dangerous. Moreover, the decision of the pathologist based on a biopsy is subjective, and depends on the sample, because the ﬁbrosis level varies along the liver. No objective standard has been developed yet for histological ﬁbrosis assessment. Magnetic resonance volume data has much lower resolution than histological image data, but it includes the entire liver volume. Also, MRI is non-invasive and not painful, thus it is preferred as a diagnostic tool. Previously it has been hypothesized that the average brightness of Apparent Diﬀusion Coeﬃcient (ADC) in diﬀusion MRI correlates with the ﬁbrosis stage.  &lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt; &lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #222; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;This project is conducted in collaboration with the Boston Medical Center. We are trying to provide tools for robust liver ﬁbrosis staging, based on MRI image analysis. The current practice of ﬁbrosis assessment, which is based on painful liver biopsy, might be dangerous. Moreover, the decision of the pathologist based on a biopsy is subjective, and depends on the sample, because the ﬁbrosis level varies along the liver. No objective standard has been developed yet for histological ﬁbrosis assessment. Magnetic resonance volume data has much lower resolution than histological image data, but it includes the entire liver volume. Also, MRI is non-invasive and not painful, thus it is preferred as a diagnostic tool. Previously it has been hypothesized that the average brightness of Apparent Diﬀusion Coeﬃcient (ADC) in diﬀusion MRI correlates with the ﬁbrosis stage.  &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Anry</name></author>
		
	</entry>
	<entry>
		<id>https://www.na-mic.org/w/index.php?title=Projects:LiverFibrosisStaging&amp;diff=78297&amp;oldid=prev</id>
		<title>Anry: Created page with '= Segmentation =  This project is conducted in collaboration with the Boston Medical Center. We are trying to provide tools for robust liver ﬁbrosis staging, based on MRI image…'</title>
		<link rel="alternate" type="text/html" href="https://www.na-mic.org/w/index.php?title=Projects:LiverFibrosisStaging&amp;diff=78297&amp;oldid=prev"/>
		<updated>2012-11-21T18:36:49Z</updated>

		<summary type="html">&lt;p&gt;Created page with &amp;#039;= Segmentation =  This project is conducted in collaboration with the Boston Medical Center. We are trying to provide tools for robust liver ﬁbrosis staging, based on MRI image…&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;New page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;= Segmentation =&lt;br /&gt;
&lt;br /&gt;
This project is conducted in collaboration with the Boston Medical Center. We are trying to provide tools for robust liver ﬁbrosis staging, based on MRI image analysis. The current practice of ﬁbrosis assessment, which is based on painful liver biopsy, might be dangerous. Moreover, the decision of the pathologist based on a biopsy is subjective, and depends on the sample, because the ﬁbrosis level varies along the liver. No objective standard has been developed yet for histological ﬁbrosis assessment. Magnetic resonance volume data has much lower resolution than histological image data, but it includes the entire liver volume. Also, MRI is non-invasive and not painful, thus it is preferred as a diagnostic tool. Previously it has been hypothesized that the average brightness of Apparent Diﬀusion Coeﬃcient (ADC) in diﬀusion MRI correlates with the ﬁbrosis stage. &lt;br /&gt;
&lt;br /&gt;
== Our Approach ==&lt;br /&gt;
&lt;br /&gt;
In our research, we have tested different ADC image texture features, and have found features &lt;br /&gt;
(e.g., standard deviation of color distribution) that correlate with histological results much better than average&lt;br /&gt;
brightness. Using the tools from visual tracking research, we have developed algorithm for&lt;br /&gt;
automatic hepatic MRI segmentation, and algorithm for automatic liver staging, based on&lt;br /&gt;
optimal feature grouping. In addition, we are developing novel topological continuous features to improve the classification.&lt;br /&gt;
&lt;br /&gt;
== Results ==&lt;br /&gt;
&lt;br /&gt;
The original liver slice for b=4 is shown in the Figure 1. The automatically segmented slice converted to Apparent Diffusion Coefficient (ADC) image, and shown in the Figure 2. Using multiple ADC image features we are able to provide automatic grading of hepatic fibrosis which correlate more than 80% with the histopathology results. This result improves the current state-of-the-art algorithms that able to classify livers only to two groups (healthy/unhealthy), with the similar correlation.&lt;br /&gt;
&lt;br /&gt;
&amp;lt;gallery&amp;gt;&lt;br /&gt;
Image:LiverDiffMRI.png|Figure 1. The original MRI data.&lt;br /&gt;
Image:LiverDiffMRI_Segmented.png|Figure 2. Automatically segmented MRI ADC.&lt;br /&gt;
&amp;lt;/gallery&amp;gt;&lt;br /&gt;
&lt;br /&gt;
= Publications = &lt;br /&gt;
&lt;br /&gt;
Nakhmani A., Anderson. S., Tannenbaum A., &amp;quot;Automatic Segmentation and Classification of Hepatic Fibrosis Grade Using Diffusion MRI,&amp;quot; In preparation. &lt;br /&gt;
&lt;br /&gt;
= Key Investigators = &lt;br /&gt;
&lt;br /&gt;
* UAB: Arie Nakhmani and Allen Tannenbaum&lt;/div&gt;</summary>
		<author><name>Anry</name></author>
		
	</entry>
</feed>